SIGLEC1 and systemic sclerosis: Upregulation of Siglec‐1 on monocytes has been observed in patients with atherosclerosis, systemic sclerosis, rheumatoid arthritis, systemic lupus erythematous and human immunodeficiency virus infections 19, 20, 21, 22, 23.